Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Active Controlled Trial of the Safety and Tolerability of MP 03-036 (Astepro 0.15%) in Patients With Perennial Allergic Rhinitis

NCT00720382 is registered in ClinicalTrials.gov with Meda Pharmaceuticals as lead sponsor.

NCT NCT00720382
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00720382 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Active Controlled Trial of the Safety and Tolerability of MP 03-036 (Astepro 0.15%) in Patients With Perennial Allergic Rhinitis
Lead sponsor
Meda Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2007
Completion date
July 31, 2008
Enrollment
703 (actual)
Sites
59

Conditions

As the registry lists them; a condition with its own page is linked.

perennial allergic rhinitis